Braunkohlenteerprodukte und das ölgas.

Por Scheithauer, W.
Publicado em 1907

Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.

Por Scheithauer, W., Schenk, T., Czejka, M.
Publicado em 1993

Hormone-containing, non-secreting pituitary tumors: clinically silent monohormonal pituitary adenomas.

Por Randall, R. V., Scheithauer, W., Laws, E. R.
Publicado em 1985

HER 2/neu protein expression in colorectal cancer

Por Zielinski Ch, Scheithauer W, Gruenberger T, Schuell B, Wrba F
Publicado em 2006-05-01

HER 2/neu protein expression in colorectal cancer

Por Schuell, B, Gruenberger, T, Scheithauer, W, Zielinski, Ch, Wrba, F
Publicado em 2006

Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours.

Por Kornek, G., Schenk, T., Raderer, M., Djavarnmad, M., Scheithauer, W.
Publicado em 1995

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

Por Scheithauer, W, Rosen, H, Kornek, G V, Sebesta, C, Depisch, D
Publicado em 1993

Human colon cancer cell lines secrete alpha TGF-like activity.

Por Hanauske, A. R., Buchok, J., Scheithauer, W., Von Hoff, D. D.
Publicado em 1987

MDR1 gene expression in primary colorectal carcinomas.

Por Pirker, R., Wallner, J., Gsur, A., Götzl, M., Zöchbauer, S., Scheithauer, W., Depisch, D.
Publicado em 1993

123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.

Por Raderer, M., Kurtaran, A., Hejna, M., Vorbeck, F., Angelberger, P., Scheithauer, W., Virgolini, I.
Publicado em 1998

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

Por Bernhard, J, Dietrich, D, Glimelius, B, Hess, V, Bodoky, G, Scheithauer, W, Herrmann, R
Publicado em 2010

Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.

Por Hejna, M., Kornek, G. V., Raderer, M., Depisch, D., Brodowicz, T., Fiebiger, W. C., Scheithauer, W.
Publicado em 1998

Side effects during chemotherapy predict tumour response in advanced colorectal cancer

Por Schuell, B, Gruenberger, T, Kornek, G V, Dworan, N, Depisch, D, Lang, F, Schneeweiss, B, Scheithauer, W
Publicado em 2005

Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancer.

Por Mader, R M, Steger, G G, Rizovski, B, Djavanmard, M P, Scheithauer, W, Jakesz, R, Rainer, H
Publicado em 1995

Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

Por Virgolini, I., Kornek, G., Höbart, J., Li, S. R., Raolerer, M., Bergmann, H., Scheithauer, W., Pantev, T., Angelberger, P., Sinzinger, H.
Publicado em 1993

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

Por Cassidy, J, Clarke, S, Díaz-Rubio, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Rittweger, K, Gilberg, F, Saltz, L
Publicado em 2011

Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.

Por Kornek, G. V., Haider, K., Kwasny, W., Hejna, M., Raderer, M., Meghdadi, S., Burger, D., Schneeweiss, B., Depisch, D., Scheithauer, W.
Publicado em 1996

Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.

Por Kornek, G. V., Haider, K., Kwasny, W., Lang, F., Krauss, G., Hejna, M., Raderer, M., Weinländer, G., Depisch, D., Scheithauer, W.
Publicado em 1998

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric...

Por Kornek, G V, Raderer, M, Schüll, B, Fiebiger, W, Gedlicka, C, Lenauer, A, Depisch, D, Schneeweiss, B, Lang, F, Scheithauer, W
Publicado em 2002

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

Por Kornek, G V, Schratter-Sehn, A, Marczell, A, Depisch, D, Karner, J, Krauss, G, Haider, K, Kwasny, W, Locker, G, Scheithauer, W
Publicado em 2000